Vanguard Group Inc. raised its holdings in shares of UiPath, Inc. (NYSE:PATH – Free Report) by 3.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 48,061,096 shares of the company’s stock after purchasing an additional 1,396,972 shares during the quarter. Vanguard Group Inc. owned 0.09% of UiPath worth $495,029,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors have also recently made changes to their positions in the company. Tidal Investments LLC lifted its holdings in UiPath by 3.7% during the 4th quarter. Tidal Investments LLC now owns 22,487 shares of the company’s stock valued at $286,000 after buying an additional 797 shares in the last quarter. True Wealth Design LLC grew its position in shares of UiPath by 18.4% in the 4th quarter. True Wealth Design LLC now owns 5,163 shares of the company’s stock worth $66,000 after buying an additional 801 shares during the last quarter. United Capital Financial Advisors LLC grew its position in shares of UiPath by 8.6% in the 4th quarter. United Capital Financial Advisors LLC now owns 12,238 shares of the company’s stock worth $156,000 after buying an additional 971 shares during the last quarter. NewEdge Advisors LLC grew its position in UiPath by 6.8% during the 4th quarter. NewEdge Advisors LLC now owns 15,809 shares of the company’s stock worth $201,000 after purchasing an additional 1,003 shares during the last quarter. Finally, Xponance Inc. grew its position in UiPath by 2.0% during the 1st quarter. Xponance Inc. now owns 54,246 shares of the company’s stock worth $559,000 after purchasing an additional 1,054 shares during the last quarter. Institutional investors own 62.50% of the company’s stock.
Insider Buying and Selling at UiPath
In other news, CFO Ashim Gupta sold 56,322 shares of the company’s stock in a transaction dated Wednesday, July 2nd. The shares were sold at an average price of $12.72, for a total transaction of $716,415.84. Following the completion of the transaction, the chief financial officer owned 859,991 shares of the company’s stock, valued at $10,939,085.52. This represents a 6.15% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Daniel Dines sold 45,000 shares of the company’s stock in a transaction dated Wednesday, July 16th. The shares were sold at an average price of $12.43, for a total transaction of $559,350.00. Following the transaction, the chief executive officer directly owned 5,058,376 shares of the company’s stock, valued at approximately $62,875,613.68. This represents a 0.88% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 831,310 shares of company stock valued at $10,428,922 in the last ninety days. Corporate insiders own 23.19% of the company’s stock.
UiPath Trading Down 2.5%
UiPath (NYSE:PATH – Get Free Report) last issued its earnings results on Thursday, May 29th. The company reported $0.11 EPS for the quarter, topping the consensus estimate of $0.10 by $0.01. The company had revenue of $356.62 million for the quarter, compared to analyst estimates of $332.17 million. UiPath had a negative net margin of 4.65% and a negative return on equity of 3.05%. The business’s revenue was up 6.4% on a year-over-year basis. During the same period in the previous year, the firm earned $0.13 EPS. As a group, equities research analysts forecast that UiPath, Inc. will post -0.17 EPS for the current fiscal year.
Wall Street Analyst Weigh In
Several analysts have recently commented on PATH shares. Wells Fargo & Company reaffirmed an “equal weight” rating on shares of UiPath in a report on Friday, May 30th. Royal Bank Of Canada increased their target price on shares of UiPath from $13.00 to $15.00 and gave the company a “sector perform” rating in a research report on Friday, May 30th. Wall Street Zen lowered shares of UiPath from a “strong-buy” rating to a “buy” rating in a report on Sunday, August 3rd. Morgan Stanley increased their target price on shares of UiPath from $12.00 to $15.00 and gave the stock an “equal weight” rating in a research note on Monday, June 2nd. Finally, Scotiabank increased their price target on shares of UiPath from $12.00 to $13.00 and gave the stock a “sector perform” rating in a research report on Friday, May 30th. Two research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $13.83.
Check Out Our Latest Stock Analysis on PATH
UiPath Profile
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
See Also
- Five stocks we like better than UiPath
- Canadian Penny Stocks: Can They Make You Rich?
- How Did Peter Thiel-Backed Crypto Exchange Bullish’s IPO Go?
- Large Cap Stock Definition and How to Invest
- Mercury Systems Up 27%: Financials Send Investors a Clear Signal
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Deereās Sell-Off Could Be a Long-Term Buying Chance
Want to see what other hedge funds are holding PATH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UiPath, Inc. (NYSE:PATH – Free Report).
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.